A step forward in prostate cancer screening optimisation
A single prostate-specific antigen (PSA) measurement in midlife may help to personalise prostate cancer screening, resulting in a reduced risk of overdiagnosis and overtreatment of indolent cancers....
View ArticleClik here to view.
Artificial intelligence for skin cancer diagnosis, from science-fiction to...
Visual data are highly suited to being handled by machines. That’s why dermatology is a candidate for an artificial intelligence-driven revolution. Automated screening and diagnosis of skin cancer will...
View ArticleClik here to view.
COVID-19 is delaying diagnosis, but getting back to normal is not what we need
Zorana Maravic is head of operations at Digestive Cancers Europe Across the globe, all human and technical resources in healthcare are currently focused on dealing with the COVID-19 pandemic, which is...
View ArticleNHS England’s pilot of cancer screening blood test raises questions
The UK National Health Service (NHS) announced on the 27 November that it would be piloting an early detection multi-cancer blood test next year. This represents an important advance because “every...
View ArticleStudy brings mass biparametric MRI screening for prostate cancer a step closer
Using biparametric (bp) magnetic resonance imaging (MRI) to screen for prostate cancer identified twice as many clinically significant cancers as standard prostate-specific antigen (PSA) tests....
View ArticleOlder, frail patients are still being let down by the regulators
Hans Wildiers is frustrated. “This drug is well-tolerated in older persons – this is a very frequent conclusion in publications. And it is often not a correct conclusion,” says the immediate past...
View ArticleClik here to view.
PSA population screening is back in favour: here’s why
Five years ago, the idea of national screening programmes for prostate cancer had gone cold. The benefits of PSA (prostate specific antigen) blood testing, introduced as a screening tool in the 1980s,...
View ArticleProstate cancer: new leads for deterring progression
Future prospects for tackling aggressive prostate cancer emerged from two presentations at the American Association for Cancer Research Annual meeting, held virtually in mid-April. One identified how...
View ArticleStudy suggests tackling loneliness could help reduce cancer in middle-aged men
Loneliness among middle-aged men is associated with increased risks of developing cancer. The longitudinal Finnish study, published in the May issue of Psychiatry Research, additionally found mortality...
View ArticleClik here to view.
Lung cancer screening: time to act on the evidence
“It’s extraordinary that screening for the biggest cancer killer is not available in most of Europe,” says Anne Marie Baird, President of Lung Cancer Europe (LuCE). “Lung cancer causes more deaths in...
View ArticleLiver cancer: how Europe can halt the rising death toll
When the cancer community in Europe talks of neglected cancers it usually means relatively rare or uncommon types, of which there are many. But conspicuous in the list are two digestive cancers that...
View ArticleClik here to view.
Liver patient advocates to Europe’s cancer community: can we talk?
Europe’s Beating Cancer plan is galvanising the cancer community behind efforts to tackle rising trends that are currently on course for an almost 25% rise in deaths from cancer across Europe by 2035....
View ArticleHow we turn lung cancer care into a European success story
Opportunities to make significant headway against cancer don’t come around very often. This year, an alignment of science and European cancer policy is opening such an opportunity in relation to lung...
View ArticlePrecision care: supporting our patients starts with asking them what they...
Two weeks after receiving a brain tumour diagnosis, Martin was copied into an email from one of his healthcare team telling his GP that Martin was “understandably devastated by his diagnosis”. The...
View ArticleClik here to view.
Global elimination: securing a future free from cervical cancer
August 7th 2020, much of the world was in various states of lockdown, anxiously awaiting news about progress in development of vaccines against the new SARS-Cov-2 virus, which by then had taken the...
View ArticleCervical cancer: Rebuilding a nation’s broken trust in their screening service
Ireland’s cervical cancer screening programme ‘CervicalCheck’ has been under the microscope since April 2018, when it was revealed that some women diagnosed with invasive cervical cancer were not told...
View ArticleUS study suggests colorectal cancer screening should start at age 45
Screening women below the age of 50 for colorectal cancer (CRC) can significantly reduce their risk in comparison to those who have no endoscopic screening or who initiate testing at age 50. The study...
View ArticleCervical cancer elimination efforts boosted by simpler ways to identify and...
Project sites in seven low-income countries have reached the 90% targets set by the World Health Organization (WHO) for treating women identified with pre-cancerous lesions. This success was achieved...
View ArticleNew prostate cancer blood test combining PSA with epigenetic test could...
A non-invasive prostate cancer combination test has been shown to have a positive predictive value of 93%*, meaning that out of 100 patients testing positive for prostate cancer 93 will truly have the...
View ArticleFood insecurity: Why screening for access to nutrition should be part of...
Sixteen-year-old Sahil Bacchav had just finished his tenth grade exams when he developed terrible headaches and a feeling that his nose was blocked. He was referred to King Edward Memorial Hospital, a...
View ArticleClik here to view.
From stigma to strategy: Egypt’s journey in combating cervical cancer
Before 2021, there was little official focus on cervical cancer in Egypt. The World Health Organization’s 2021 report indicated that fewer than 1 in 10 Egyptian women had been screened for cervical...
View Article
